vs

Side-by-side financial comparison of MEDIFAST INC (MED) and SHENANDOAH TELECOMMUNICATIONS CO (SHEN). Click either name above to swap in a different company.

SHENANDOAH TELECOMMUNICATIONS CO is the larger business by last-quarter revenue ($91.6M vs $75.1M, roughly 1.2× MEDIFAST INC). On growth, SHENANDOAH TELECOMMUNICATIONS CO posted the faster year-over-year revenue change (7.2% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-78.6M). Over the past eight quarters, SHENANDOAH TELECOMMUNICATIONS CO's revenue compounded faster (15.0% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.

MED vs SHEN — Head-to-Head

Bigger by revenue
SHEN
SHEN
1.2× larger
SHEN
$91.6M
$75.1M
MED
Growing faster (revenue YoY)
SHEN
SHEN
+44.1% gap
SHEN
7.2%
-36.9%
MED
More free cash flow
MED
MED
$72.0M more FCF
MED
$-6.6M
$-78.6M
SHEN
Faster 2-yr revenue CAGR
SHEN
SHEN
Annualised
SHEN
15.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
SHEN
SHEN
Revenue
$75.1M
$91.6M
Net Profit
$-5.4M
Gross Margin
69.4%
Operating Margin
-10.4%
-1.0%
Net Margin
-5.9%
Revenue YoY
-36.9%
7.2%
Net Profit YoY
-95.8%
EPS (diluted)
$-1.64
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SHEN
SHEN
Q4 25
$75.1M
$91.6M
Q3 25
$89.4M
$89.8M
Q2 25
$105.6M
$88.6M
Q1 25
$115.7M
$87.9M
Q4 24
$119.0M
$85.4M
Q3 24
$140.2M
$87.6M
Q2 24
$168.6M
$85.8M
Q1 24
$174.7M
$69.2M
Net Profit
MED
MED
SHEN
SHEN
Q4 25
$-5.4M
Q3 25
$-2.3M
$-9.4M
Q2 25
$2.5M
$-9.0M
Q1 25
$-772.0K
$-9.1M
Q4 24
$-2.7M
Q3 24
$1.1M
$-5.3M
Q2 24
$-8.2M
$-12.9M
Q1 24
$8.3M
$214.7M
Gross Margin
MED
MED
SHEN
SHEN
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
SHEN
SHEN
Q4 25
-10.4%
-1.0%
Q3 25
-4.6%
-8.0%
Q2 25
-1.0%
-10.3%
Q1 25
-1.1%
-6.9%
Q4 24
0.6%
-6.7%
Q3 24
1.5%
-4.8%
Q2 24
-4.7%
-18.5%
Q1 24
4.5%
-4.0%
Net Margin
MED
MED
SHEN
SHEN
Q4 25
-5.9%
Q3 25
-2.5%
-10.5%
Q2 25
2.3%
-10.2%
Q1 25
-0.7%
-10.4%
Q4 24
-3.2%
Q3 24
0.8%
-6.0%
Q2 24
-4.8%
-15.0%
Q1 24
4.8%
310.0%
EPS (diluted)
MED
MED
SHEN
SHEN
Q4 25
$-1.64
$-0.13
Q3 25
$-0.21
$-0.20
Q2 25
$0.22
$-0.19
Q1 25
$-0.07
$-0.19
Q4 24
$0.08
$-0.34
Q3 24
$0.10
$-0.13
Q2 24
$-0.75
$-0.24
Q1 24
$0.76
$4.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SHEN
SHEN
Cash + ST InvestmentsLiquidity on hand
$167.3M
$27.3M
Total DebtLower is stronger
$642.4M
Stockholders' EquityBook value
$198.9M
$880.8M
Total Assets
$248.0M
$1.9B
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SHEN
SHEN
Q4 25
$167.3M
$27.3M
Q3 25
$173.5M
$22.6M
Q2 25
$162.7M
$29.1M
Q1 25
$164.6M
$87.5M
Q4 24
$162.3M
$46.3M
Q3 24
$170.0M
$43.1M
Q2 24
$163.5M
$43.8M
Q1 24
$156.4M
$389.7M
Total Debt
MED
MED
SHEN
SHEN
Q4 25
$642.4M
Q3 25
$535.4M
Q2 25
$513.1M
Q1 25
$515.8M
Q4 24
$418.0M
Q3 24
$345.2M
Q2 24
$297.4M
Q1 24
$298.7M
Stockholders' Equity
MED
MED
SHEN
SHEN
Q4 25
$198.9M
$880.8M
Q3 25
$214.7M
$892.7M
Q2 25
$216.0M
$902.0M
Q1 25
$211.0M
$910.5M
Q4 24
$210.1M
$918.6M
Q3 24
$207.3M
$925.4M
Q2 24
$205.3M
$933.1M
Q1 24
$211.0M
$871.6M
Total Assets
MED
MED
SHEN
SHEN
Q4 25
$248.0M
$1.9B
Q3 25
$268.2M
$1.9B
Q2 25
$269.3M
$1.8B
Q1 25
$280.0M
$1.8B
Q4 24
$284.2M
$1.7B
Q3 24
$291.2M
$1.7B
Q2 24
$293.5M
$1.7B
Q1 24
$302.8M
$1.4B
Debt / Equity
MED
MED
SHEN
SHEN
Q4 25
0.73×
Q3 25
0.60×
Q2 25
0.57×
Q1 25
0.57×
Q4 24
0.46×
Q3 24
0.37×
Q2 24
0.32×
Q1 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SHEN
SHEN
Operating Cash FlowLast quarter
$-5.3M
$28.8M
Free Cash FlowOCF − Capex
$-6.6M
$-78.6M
FCF MarginFCF / Revenue
-8.8%
-85.8%
Capex IntensityCapex / Revenue
1.8%
117.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-257.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SHEN
SHEN
Q4 25
$-5.3M
$28.8M
Q3 25
$12.1M
$30.7M
Q2 25
$-3.4M
$20.9M
Q1 25
$3.4M
$20.5M
Q4 24
$-4.9M
$20.6M
Q3 24
$9.1M
$24.3M
Q2 24
$13.1M
$2.5M
Q1 24
$7.3M
$15.2M
Free Cash Flow
MED
MED
SHEN
SHEN
Q4 25
$-6.6M
$-78.6M
Q3 25
$10.8M
$-51.4M
Q2 25
$-4.8M
$-65.3M
Q1 25
$1.9M
$-62.7M
Q4 24
$-7.2M
$-72.0M
Q3 24
$7.7M
$-51.3M
Q2 24
$11.1M
$-78.3M
Q1 24
$5.4M
$-54.9M
FCF Margin
MED
MED
SHEN
SHEN
Q4 25
-8.8%
-85.8%
Q3 25
12.0%
-57.2%
Q2 25
-4.5%
-73.7%
Q1 25
1.6%
-71.3%
Q4 24
-6.1%
-84.3%
Q3 24
5.5%
-58.5%
Q2 24
6.6%
-91.3%
Q1 24
3.1%
-79.3%
Capex Intensity
MED
MED
SHEN
SHEN
Q4 25
1.8%
117.2%
Q3 25
1.5%
91.4%
Q2 25
1.3%
97.3%
Q1 25
1.3%
94.7%
Q4 24
1.9%
108.4%
Q3 24
1.0%
86.2%
Q2 24
1.1%
94.2%
Q1 24
1.1%
101.2%
Cash Conversion
MED
MED
SHEN
SHEN
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×
0.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

SHEN
SHEN

Residential And SMB Incumbent Broadband$41.5M45%
Residential And SMB Glo Fiber Expansion Markets$23.0M25%
Commercial Fiber$20.3M22%
RLEC Other$6.8M7%

Related Comparisons